PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
24-Apr-2020 ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine ReiThera
24-Apr-2020 Biocomposites announces new CE Mark for STIMULAN® Optimum Strategic Communications
24-Apr-2020 Testing of anti-viral for treating COVID-19 underway Open Orphan plc
24-Apr-2020 EASE Study Enrollment Closed; Top Line Data Expected in Late Q3/Early Q4 2020 Amryt Pharma plc
24-Apr-2020 New commitment to SwanBio in Syncona’s largest Series A financing Syncona Ltd
24-Apr-2020 Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in relapsing multiple sclerosis Sanofi
24-Apr-2020 Sofinnova Partners co-led Series A Financing for Nitrome Biosciences Raising $38M Sofinnova Partners
24-Apr-2020 The UK looks to healthtech startups as coronavirus pandemic puts spotlight on fast-growing sector DCMS
24-Apr-2020 UK flow chemistry firm in fight against COVID19 Vapourtec
24-Apr-2020 Emergex Signs Agreement with George Mason University for Highly Pathogenic RNA Virus Studies Emergex
23-Apr-2020 JPT Peptide Technologies BioNTech
22-Apr-2020 COVID-19 – Intergrated Vaccination and Immunodiagnostic Platform Viravaxx AG
22-Apr-2020 Clinical trials company recognised with royal business award Innovative Trials
22-Apr-2020 Panthera is open for clinical trials in Manchester Panthera Biopartners
22-Apr-2020 Novartis announces new Mayzent® (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis (SPMS) Novartis
22-Apr-2020 XenoGesis wins prestigious Queen’s Award for Enterprise in recognition of export growth XenoGesis
22-Apr-2020 Ricardo helps Isansys scale up production of its life-saving innovation in healthcare Ricardo
22-Apr-2020 VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus Cara Therapeutics
22-Apr-2020 ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer ERYTECH Pharma
22-Apr-2020 Futura files for Further Pre-Submission meeting with the FDA following receipt of its Phase 3 clinical study report Futura Medical plc